Tan, [email protected] This article was submitted to Obesity, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Researchers are still evaluating its effectiveness, dosing, side effects, and long-term safety
Sign up for the Health Lab Podcast
The surge in Ozempic lawsuits filed has prompted coordinated discovery protocols requiring Novo Nordisk and Eli Lilly to produce millions of pages of internal documents, including clinical trial data, adverse event reports, marketing materials, and communications about known risks
Zhao, W., Zhang, X., Zhou, Z., Sun, B., Gu, W., Liu, J., & Zhang, H
The Profit Motive Behind GLP-1 Telehealth Clinics Obesity and the desire to lose weight are not new